GSK, Teva quietly settle Coreg 'skinny label' dispute after long legal back-and-forth

11th February 2026 Uncategorised 0

Following a more than decade-long legal back-and-forth over the generic drug carveout practice known as “skinny” labeling, GSK and Teva have put their dispute to bed, new court documents show.

More: GSK, Teva quietly settle Coreg 'skinny label' dispute after long legal back-and-forth
Source: fierce